drugset / Trial / NCT00249574
Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
Completed
10 enrolled
National Institute on Drug Abuse (NIDA)
Organization to Achieve Solutions in Substance Abuse (OASIS) · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine.
Timeline
- Start
- 2003-06
- Primary completion
- 2004-03
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peginterferon alfa-2a | Protein / enzyme biologic | 180 ug | Subcutaneous |
| Subject | Ribavirin | Small molecule | 800 mg | — |
| Subject | Ribavirin | Small molecule | 1200 mg | — |
| Background | Buprenorphine | Other / unclassified | — | — |
| Background | Naloxone | Small molecule | — | — |